300759:SZSEPharmaron Beijing Co., Ltd. Class A Analysis

Pharmaron Beijing Co., Ltd. trades at ¥46.42, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 25.7%. Momentum indicators put RSI at 57.1 (neutral) with MACD reading bearish. Recent trading has carved out support near ¥34.83 and resistance around ¥53.57.
Multiples put this in overvalued territory: 48.9 times earnings against the sector's 31.3. Sell-side targets cluster 4.8% above the current quote. Revenue is growing at 20.2% on a 11.2% profit margin. The 0.45% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 78.5%, a beta of 0.61 and a maximum drawdown of 39.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.